This observation also aligns with previous studies reporting elevated expression of COL6A2 or other type VI collagen chains in various malignancies, including glioma, breast cancer, lung cancer, colorectal cancer, and gastric cancer 20-27. Here, COL6A2 is linked to central nervous system cancer.